Related Experiment Videos
The management of pain in sickle cell disease
M Yaster1, S Kost-Byerly, L G Maxwell
1Department of Anesthesiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. myaster@jhmi.edu
Pediatric Clinics of North America
|June 3, 2000
Abstract:
The pain of vaso-occlusive crisis in patients with sickle cell disease is excruciating, incapacitating, and sometimes refractory to even the most advanced analgesic treatments. A comprehensive, multimodal approach to therapy that includes education, cognitive therapies, anti-inflammatory drugs, opioids, and psychostimulant adjuvant drugs has been presented. Until a cure for the underlying disease is found, these are the best approaches available. The authors hope that future research will find even better modalities of analgesic care.